Manuel Grundmann
Bayer (Germany)(DE)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Diabetes Treatment and Management, Protein Kinase Regulation and GTPase Signaling, Pancreatic function and diabetes
Most-Cited Works
- → Lack of beta-arrestin signaling in the absence of active G proteins(2018)367 cited
- → The experimental power of FR900359 to study Gq-regulated biological processes(2015)360 cited
- → Applying label-free dynamic mass redistribution technology to frame signaling of G protein–coupled receptors noninvasively in living cells(2011)175 cited
- → Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists(2011)122 cited
- → Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases(2015)115 cited
- → Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators(2021)113 cited
- → Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs(2012)89 cited
- → Temporal Bias: Time-Encoded Dynamic GPCR Signaling(2017)85 cited
- → Reevaluation of Fatty Acid Receptor 1 as a Drug Target for the Stimulation of Insulin Secretion in Humans(2013)71 cited
- → Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes(2013)68 cited